Financial Data and Key Metrics Changes - The total company revenue for Q4 2025 was $157.3 million, with EPS of $0.14 and adjusted EBITDA of $23.8 million, all exceeding Q4 guidance [20] - For continuing operations, Q4 broadband revenue was $98.2 million, above the guidance range of $85 million to $95 million, with adjusted EBITDA of $12.1 million and EPS of $0.06 [21] - The total company net revenue for the full year 2025 was $570.8 million, with a gross margin of 55.8%, adjusted EBITDA of $83.8 million, and EPS of $0.47 [22] Business Line Data and Key Metrics Changes - Broadband revenue for Q4 was $98.2 million, reflecting a 9% sequential growth and record quarterly bookings of $346.9 million, resulting in a 3.5 book-to-bill ratio [5][20] - The video business, now classified as discontinued operations, exceeded expectations in Q4 in terms of revenue and profitability, with a planned sale to MediaKind for approximately $145 million [6] - Rest-of-world revenue grew 33% year-over-year in Q4, now representing 41% of total broadband revenue, indicating a shift in revenue mix and diversification efforts [7][21] Market Data and Key Metrics Changes - The cable serviceable addressable market is expected to grow from approximately $510 million in 2025 to over $1.1 billion by 2030, driven by increased data consumption and network modernization [14] - The addressable market for fiber exceeds $2.6 billion, with Harmonic's share growing, indicating significant opportunities in this segment [15] Company Strategy and Development Direction - The company is transitioning to a pure-play broadband leader following the sale of its video business, focusing on broadband infrastructure and simplifying its operating model [4][17] - The long-term strategy includes expanding market leadership in DOCSIS, increasing customer diversification, driving software and cloud differentiation, and maintaining operational discipline [16] - The company aims for sustained rest-of-world growth of 30% or more annually, expanding beyond its largest North American customers [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth trajectory as DOCSIS 4.0 and fiber deployment scale through 2026 and beyond, supported by strong demand and cash generation [34] - The company anticipates significant full-year broadband revenue growth in 2026, driven by strong bookings and backlog [20][24] Other Important Information - The company ended the year with a strong balance sheet, including $124.1 million in cash and cash equivalents, and a significant capital infusion expected from the video business sale [23][26] - The company has a $200 million share repurchase program, with $101 million already repurchased, indicating a commitment to returning capital to shareholders [28] Q&A Session Summary Question: Customer mix for full year 2026 - Management indicated that while rest-of-world customers showed strong growth, the percentage of revenue from these customers may fluctuate based on larger customer spending [39][40] Question: Gross margin expectations and memory costs - Management confirmed an estimated $6 million impact from memory pricing, with a focus on maintaining margin guidance despite potential headwinds [41][42][43] Question: Bookings composition in Q4 - Management noted that bookings were strong across both larger customers and rest-of-world, with multi-year contracts contributing to the backlog [61][76] Question: SaaS and service revenue breakdown - The majority of the $58 million in SaaS revenue was from SLA contracts, with a focus on growing intelligence and tools for customers [78][80]

Financial Data and Key Metrics Changes - In Q3 2025, the company's revenue was $2 million, a 24% decrease from $2.5 million in Q3 2024, primarily due to a timing reduction in IHP services sales from a key customer [9][10] - Year-to-date service demand remains robust, with quote activity and pipeline volume up approximately 35% year over year in the life sciences and food safety areas [10] - Gross profit margins remained strong at 61% for Q3 2025, consistent with the same period last year [10] Business Line Data and Key Metrics Changes - Recurring BIP solution sales increased by 21% year to date, contributing to the overall revenue growth [5][10] - The sales order backlog was $0.9 million at the quarter end and grew to $1.3 million by October 31, with approximately $3 million in pending SteraMist integration contracts expected to close before year-end [6][10] Market Data and Key Metrics Changes - The FDA's broadened approval of hydrogen peroxide as a safe disinfectant opens new markets, particularly in food processing and agriculture [7][23] - The company is seeing strong interest from emerging sectors, with an active pipeline surpassing $15 million [6][7] Company Strategy and Development Direction - The company aims to grow sales of mobile capital equipment, IHP corporate service, and custom integration platforms alongside its core BIP solution business model [5][8] - There is a focus on biosecurity advancements and scaling automation integrations for high-efficacy environments, addressing global challenges [8][9] Management's Comments on Operating Environment and Future Outlook - Management believes the third quarter marked a decisive turning point, with a 95% sequential revenue increase driven by expanding recurring revenue streams [4][5] - The company is optimistic about the future, with a strong sales backlog and a sales strategy beginning to deliver promising results [25][26] Other Important Information - The company entered into an equity purchase agreement with Hudson Global Ventures, allowing it to sell up to $20 million in common stock over a 24-month period [26] - The SteraMist IHP technology was named the Disinfection and Decontamination Products Company of the Year 2025 [7] Q&A Session Summary Question: What are the sales and marketing efforts towards the FDA approval for hydrogen peroxide usage? - Management sees the food industry as a key marketing vertical and is excited about the approval, which is expected to be a game changer [29] Question: Should operating expenses and gross margins continue to improve? - Management expects operating expenses to increase but believes they will be positive in relation to revenue, with gross margins remaining stable [30][31] Question: What kind of sales effort is in place for international markets like Morocco? - The company has different distributors in various countries and is working with global partners to increase demand for SteraMist [34] Question: What visibility is there on solution sales in the coming quarters? - Management anticipates that solution sales will increase as more technology is deployed, with a key focus on driving growth in BIP solution sales [35] Question: Any updates on servicing military and defense markets? - The company is working with a key site looking to replace formaldehyde and expects significant developments in 2026 [42] Question: Any progress in the use of SteraMist for replacing ethylene oxide in medical instrument sterilization? - The company is prioritizing partnerships in device manufacturing to streamline IHP into decontamination processes [51]